Thanks to its diverse product portfolio, GE Healthcare has increased its lead over Philips Healthcare and Siemens Healthcare in the $1.2 billion U.S. ultrasound market, according to a report from Millennium Research Group.
The Toronto-based research firm also found that the Chalfont St. Giles, U.K.-based vendor grew its share in the fast-growing emerging ultrasound system segment from 10% in 2007 to 29% in 2009. The emerging application segment includes systems used for regional anesthesia, emergency medicine, surgery, critical care, and vascular access, Millennium said.
Growth in this sector is expected to dwarf gains in the traditional radiology and cardiology ultrasound markets, according to Millennium. The research firm said that GE's strategic focus on new product offerings in this segment situates the company well for strong growth through 2014.
Related Reading
Strong growth projected for OCT market, September 15, 2010
Report: Imaging sales to drop 15% in emerging markets, April 23, 2009
Report: Digital mammography market surging, May 9, 2007
Image-guided surgery market in U.S. to reach $300 million, January 16, 2007
Fetal 4D US market grows despite FDA criticism, research finds, November 30, 2006
Copyright © 2010 AuntMinnie.com
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)